Butterfly Network (BFLY) Return on Capital Employed (2020 - 2026)
Butterfly Network (BFLY) reported Return on Capital Employed of 35.32% for Q1 2026, down 662.0% on a YoY basis from 6.28% in Q1 2025, and up 6.75% sequentially from 37.88% in Q4 2025.
Butterfly Network (BFLY) Return on Capital Employed (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Return on Capital Employed data on file, last reported at 35.32% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 662.0% year-over-year to 35.32%; the trailing twelve-month figure through Mar 2026 stood at 35.32% (down 662.0% YoY), and the FY2025 full-year result was 40.92%, down 884.0% from the prior year.
- Return on Capital Employed improved to 35.32% in Q1 2026, from 37.88% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 25.49% in Q2 2025 to a low of 52.95% in Q4 2023.
- A 5-year average of 42.59% and a median of 44.65% in 2022 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed slumped 1439 bps in 2022 and surged 2459 bps in 2025, its largest moves.
- Tracing BFLY's Return on Capital Employed over 5 years: stood at 50.92% in 2022, then decreased by 4 bps to 52.95% in 2023, then jumped by 34 bps to 35.02% in 2024, then fell by 8 bps to 37.88% in 2025, then gained by 7 bps to 35.32% in 2026.
- Business Quant data shows BFLY's Return on Capital Employed at 35.32% in Q1 2026, 37.88% in Q4 2025, and 34.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 8.38% |
| 10 | Butterfly Network | 1.75 Bn | 1.61 Bn | 18.29 Mn | -35.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.32% |
| Dec 31, 2025 | -37.88% |
| Sep 30, 2025 | -34.62% |
| Jun 30, 2025 | -25.49% |
| Mar 31, 2025 | -28.70% |
| Dec 31, 2024 | -35.02% |
| Sep 30, 2024 | -45.87% |
| Jun 30, 2024 | -50.08% |
| Mar 31, 2024 | -52.69% |
| Dec 31, 2023 | -52.95% |
| Sep 30, 2023 | -48.64% |
| Jun 30, 2023 | -49.30% |
| Mar 31, 2023 | -50.32% |
| Dec 31, 2022 | -50.92% |
| Sep 30, 2022 | -44.65% |
| Jun 30, 2022 | -44.13% |
| Mar 31, 2022 | -37.48% |
| Dec 31, 2021 | -36.62% |
| Sep 30, 2021 | -30.26% |
| Jun 30, 2021 | -35.19% |